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Abstract
A peptide corresponding to the N-terminal region of the S protein of hepatitis B virus (Met-Glu-Asn-Ile-Thr-Ser-Gly-Phe-
Leu-Gly-Pro-Leu-Leu-Val-Leu-Gln) has been previously demonstrated to perform aggregation and destabilization of acidic
liposome bilayers and to adopt a highly stable L-sheet conformation in the presence of phospholipids. The changes in the
lipid moiety produced by this peptide have been followed by fluorescence depolarization and electron microscopy. The later
was employed to determine the size and shape of the peptide-vesicle complexes, showing the presence of highly aggregated
and fused structures only when negatively charged liposomes were employed. 1,6-Diphenyl-1,3,5-hexatriene depolarization
measurements showed that the interaction of the peptide with both negatively charged and zwitterionic liposomes was
accompanied by a substantial reduction of the transition amplitude without affecting the temperature of the gel-to-liquid
crystalline phase transition. These data are indicative of the peptide insertion inside the bilayer of both types of liposomes
affecting the acyl chain order, though only the interaction with acidic phospholipids leads to aggregation and fusion. This
preferential destabilization of the peptide towards negatively charged phospholipids can be ascribed to the electrostatic
interactions between the peptide and the polar head groups, as monitored by 1-(4-(trimethylammoniumphenyl)-6-phenyl-
1,3,5-hexatriene fluorescence depolarization analysis. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
The entry of enveloped viruses into their host cells
requires the fusion between the viral and cellular
plasma or endosomal membranes. In order to
achieve the coalescence of the two bilayers, the ma-
jority of the best studied viruses possesses a clearly
de¢ned hydrophobic stretch of amino acids referred
to as the fusion peptide [1,2]. In most cases, this
fusion peptide is located at the N-terminus of one
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of the envelope glycoproteins and results from the
proteolytic processing of a polyprotein precursor. Se-
quence comparison among fusion peptides from dif-
ferent virus families reveals a few common features,
such as the presence of the Phe-Leu-Gly tripeptide
and a general high frequency of Gly residues, in-
dicative of the conformational plasticity that they
exhibit [1,2]. In the case of the well studied hemag-
glutinin protein (HA) from in£uenza virus, activa-
tion occurs by the development of the acidic pH of
the endosome, triggering a massive conformational
change that projects the fusion peptide into the mem-
brane of the host cell. This fusion peptide is located
at the N-terminal end of the HA2 subunit, and is
responsible for overcoming the strong repulsive hy-
dration, steric and electrostatic barriers that preclude
the two membranes from coalescence and fusion. In-
terestingly, in the pre-activated, pre-fusogenic neutral
pH state, the conformation of the fusion peptide
consists of a series of sequential folds, similar to
random coil, according to the high resolution crys-
tallographic data available in the case of the HA
glycoprotein [3,4]. However, after exposure of the
hemagglutinin fusion peptide at acidic pH, its inser-
tion inside the endosome membrane is accompanied
by the adoption of an K-helical conformation that
perturbs the bilayer integrity [5,6].
In the absence of an adequate in vitro system to
analyze human hepadnavirus infection and perform
site-directed mutagenesis studies, the initial infective
steps of hepatitis B virus (HBV) remain elusive at
present. Sequence comparison with amino-terminal
fusion peptides from both the paramyxovirus and
retrovirus families pointed out the possibility that
the N-terminus of the S protein of HBV might be
a fusion peptide [7]. A synthetic 16 amino acid pep-
tide comprising this region was subsequently shown
to interact with soybean asolectin phospholipids
and to mediate liposome aggregation, lipid mixing
and liposome leakage in a pH-dependent manner
[8,9]. The close apposition of membranes and the
destabilization of the bilayers needed to perform
these e¡ects take place only when negatively charged
phospholipids are present [9]. Also, synthetic oligo-
peptides corresponding to the N-terminal region of
the S protein of other representative hepadnaviruses
possess these destabilizing properties [10]. The HBV
putative fusion peptide adopts mainly a highly stable
L-sheet structure when interacting with acidic and
neutral phospholipid vesicles, as demonstrated by
circular dichroism (CD) and Fourier transform infra-
red spectroscopy techniques [11]. The aim of this
report is the characterization of the lipid moiety al-
teration upon addition of the fusion peptide by
means of electron microscopy and £uorescence depo-
larization of two probes incorporated into the lipid
bilayer. Our results suggest that the peptide is indeed
fusogenic and although the peptide inserts in both
negatively charged and zwitterionic phospholipid
vesicles, electrostatic interactions between the fusion
peptide and the polar head groups rather than hy-
drophobic forces might be responsible for the pref-
erential aggregation and fusion observed towards
acidic phospholipid vesicles.
2. Materials and methods
2.1. Chemicals
Egg phosphatidylcholine (PC), bovine brain phos-
phatidylserine (PS), dimyristoylphosphatidylcholine
(DMPC), dimyristoylphosphatidylserine (DMPS)
and dimyristoylphosphatidylglycerol (DMPG) were
provided by Avanti Polar Lipids. 1,6-Diphenyl-
1,3,5-hexatriene (DPH) and 1-(4-(trimethylammo-
niumphenyl)-6-phenyl-1,3,5-hexatriene (TMA-DPH)
were purchased from Molecular Probes. All other
reagents were from Merck.
2.2. Peptide synthesis
A 16 amino acid peptide covering the amino-ter-
minal region of the S protein of HBsAg (sequence:
Met-Glu-Asn-Ile-Thr-Ser-Gly-Phe-Leu-Gly-Pro-Leu-
Leu-Val-Leu-Gln) was synthesized as the carboxy-
terminal amide on an automated multiple peptide
synthesizer (AMS 422, Abimed) using a solid-phase
procedure and standard Fmoc chemistry in a base of
25 Wmol as previously described [9]. The peptide was
puri¢ed by reverse-phase HPLC on a C-18 column.
Purity and composition of the peptide were con-
¢rmed by reverse-phase HPLC and by amino acid
analysis [9].
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2.3. Electron microscopy
The peptide-vesicle complexes were obtained by
incubating phospholipid vesicles (obtained by extru-
sion through a 0.1 mm pore diameter polycarbonate
¢lter) [9] at 0.14 mM lipid concentration with peptide
at a ¢nal concentration of 39 WM for 1 h at 37‡C.
Both the vesicles and the peptide-vesicle complexes
were subjected to negative staining with phospho-
tungstic acid and observed in formvar-carbon grids.
In general, the grid was subjected to a glow discharge
in order to enhance its adherence properties and was
immediately deposited over a drop of the sample for
approx. 2 min. Afterwards, the grid was dried and
stained with 1.7% (w/v) phosphotungstic acid, pH 7.2
for 1 min. Finally, the grid was dried and subjected
to vacuum drying for 30 min. If the sample to be
stained was at pH 5.0, an additional step of 1 min
equilibration in medium bu¡er, pH 7.3, was included
after incubation of the sample with the grid. Samples
were examined using a Zeiss EM 902 (Jena, Ger-
many) transmission electron microscope operating
at 80 kV.
2.4. Fluorescence polarization
Two di¡erent probes were employed in the depo-
larization experiments: DPH and TMA-DPH. The
former was dissolved in tetrahydrofuran and added
to the lipid chloroform solution at a 1:500 ratio (w/
w), and the latter was dissolved in methanol and
added to the lipid chloroform solution at a 1:100
ratio (w/w). Lipid aliquots were dried under a nitro-
gen current for at least 30 min and were ¢nally kept
in vacuum overnight. Hydration was performed in
1.5 ml of medium bu¡er (100 mM NaCl, 5 mM
Tris, 5 mM sodium citrate, 5 mM MES) adjusted
to the appropriate pH value at 42‡C for 1 h. The
lipid vesicles were then sonicated for 30 min in a
bath sonicator (Branson 1200) in order to obtain
small unilamellar vesicles. The sample was divided
into three 0.5 ml aliquots, each of them at 0.14
mM lipid. DMSO was added to one of these aliquots
(control) and peptide from a concentrated DMSO
stock solution was added to the other two (3.5^28
WM ¢nal concentration). The concentration of
DMSO was kept below 1.5%. The three samples
were measured at a time in 0.2U1 cm £uorescence
cuvettes. A SLM Aminco 8000C spectro£uorimeter
equipped with Glan Thompson polarizers was em-
ployed, setting the slits to 4 nm. The probes were
excited at 365 nm and the £uorescence emission
was measured at 425 nm. The temperature in the
cuvette was maintained with a Polystat Huber circu-
lating water bath.
3. Results
3.1. Electron microscopy
Previous data obtained with the HBV N-terminal
peptide indicated that it was able to perform the
essential steps required for fusion when acidic phos-
pholipids were present in the assays but it was unable
to induce these e¡ects when added to neutral phos-
pholipids even at elevated concentrations [8,9]. In
order to inspect the changes induced in the liposome
morphology upon addition of the N-terminal pep-
tide, both natural phospholipid vesicles and vesicle-
peptide complexes were observed by negative stain-
ing electron microscopy. Fig. 1 shows the control PS
(A) and PC liposomes (C) negatively stained with
phosphotungstic acid in the absence of added pep-
tide. In both panels, a homogeneous population of
vesicles, averaging 102 þ 20 nm (Fig. 1A) and
104 þ 20 nm (Fig. 1C), can be observed. Addition
of the peptide to bovine brain PS liposomes led to
an increase in vesicle size. Together with some orig-
inal vesicles, large aggregates and fused structures of
240 þ 55 nm were observed (Fig. 1B). In the case of
egg PC liposomes the vesicle size did not change
signi¢cantly (100 þ 25 nm) upon addition of the pep-
tide (Fig. 1D). Therefore, the N-terminal peptide of
HBV induced the fusion of negatively charged phos-
pholipid vesicles, but was unable to promote aggre-
gation or fusion of neutral phospholipid liposomes.
3.2. Fluorescence depolarization measurements
Although not analogous to natural phospholipids,
synthetic dimyristoyl phospholipids were used to as-
sess the e¡ect of the N-terminal fusion peptide on the
lipid phase transition. Fluorescence depolarization of
DPH and its polar derivative TMA-DPH incorpo-
rated into the bilayer was measured after interaction
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of the peptide with the vesicles for 1 h at 37‡C. The
two £uorescent probes were employed in the assays
so that the £uidity of both the inner and the outer
part of the bilayer could be monitored. DPH is as-
sumed to be aligned with the phospholipid acyl
chains giving information of the hydrophobic core
of the bilayer, whereas TMA-DPH has a shallower
location due to the anchoring of its non-£uorescent
polar moiety to the lipid/water interface and interacts
with both the phospholipid polar head groups and
the fatty acyl chain region, probably as far down as
C8-C10 [12^14]. Fig. 2 shows the £uorescence depo-
larization of DPH-labeled DMPS liposomes at both
pH 7.3 and pH 5.0 upon interaction with the fusion
peptide at two di¡erent concentrations. In the ab-
sence of added peptide, the DMPS vesicles displayed
a cooperative transition, being the gel-to-liquid crys-
talline transition temperature (Tm) 35.5‡C at pH 7.3
and 39‡C at pH 5.0, in good agreement with pub-
lished data [15,16]. This displacement in the DMPS
phase transition towards higher temperatures togeth-
er with the slight diminishment in the polarization
amplitude, and hence in the transition enthalpy val-
ue, is due to the partial protonation of the serine
carboxylate (pKapp = 5.5) [16]. Addition of the pep-
tide modi¢es the phase transition curves of the
Fig. 1. Electron micrographs of liposomes and liposome-HBV peptide complexes. The complexes were obtained by incubating the
vesicles (0.14 mM, ¢nal concentration) with the peptide (39 WM, ¢nal concentration) in medium bu¡er at pH 5.0 for 1 h at 37‡C. Bo-
vine brain PS vesicles in the absence (A) or presence (B) of the HBV peptide, and egg PC vesicles in the absence (C) or presence (D)
of the HBV peptide were used to coat glow-discharged formvar-carbon grids as described in Section 2. The grids were subsequently
stained with phosphotungstic acid. The bar represents 150 nm.
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vesicles both at pH 7.3 and pH 5.0. The amplitude of
the phase transition decreased as a consequence of
the increase in DPH £uorescence polarization of the
liquid-crystalline state without signi¢cant changes in
the transition temperature. The interaction of the
peptide with the acyl chains scarcely a¡ected the
gel state, since the polarization values below the Tm
remain unmodi¢ed. These e¡ects on the thermo-
tropic behavior of the phospholipid are those of an
integral molecule which restricts the mobility of the
acyl chains, suggesting the insertion of the peptide
into the membrane. The modi¢cations on the ther-
mal transition induced by the peptide are signi¢-
cantly more profound at pH 5.0, with 28 WM peptide
almost completely abolishing the gel-to-£uid phase
transition (Fig. 2, right) while the same peptide con-
centration reduced the transition amplitude by 60%
at pH 7.3 (Fig. 2, left). This increased interaction is
likely due to the partial protonation of the side chain
of the glutamic acid at position 2 of the peptide upon
lowering the pH, allowing a deeper penetration with-
in the bilayer.
Insertion of the peptide took place into acidic
phospholipids with di¡erent polar head groups since
a similar trend to that described for DMPS is ob-
served when the peptide was added to DMPG
vesicles, employing the probe DPH at both neutral
and acidic pH (Fig. 3). Although no variation of Tm
is observed, the amplitude of the gel-to-liquid crys-
talline transition decreased when the peptide was
present. As described for the DMPS vesicles, the
changes in the £uorescence polarization were ob-
served only at temperatures above the Tm of the
transition, indicative that the peptide preferentially
alters the phospholipid acyl chain in its £uid state.
Also, the e¡ect observed at pH 5.0 was more pro-
found than at pH 7.3. Moreover, at pH 5.0 the e¡ect
caused by the peptide is larger on the DMPG than
on the DMPS vesicles since 17.5 WM peptide is
enough to almost completely abolish the DMPG
phase transition while that peptide concentration re-
duced the DMPS transition by 50%. This di¡erence
could be due to either a di¡erent partitioning of the
peptide into these two phospholipids or to the re-
duced ability of phosphatidylglycerol, in comparison
with phosphatidylserine, to form an extensive inter-
molecular hydrogen bond network that would pre-
vent, to some extent, the peptide from disrupting the
bilayer integrity [17].
As indicated by electron microscopy the fusion
Fig. 2. Temperature dependence of the £uorescence polarization of DPH-labeled DMPS vesicles. Phosphatidylserine liposomes were
prepared by hydration of a dry lipid ¢lm in medium bu¡er at pH 7.3 (left) or pH 5.0 (right) followed by bath sonication. The vesicles
were incubated for 1 h at 37‡C in the presence of 17.5 WM (F) or 28 WM (R) HBV peptide dissolved in DMSO. In every case, a con-
trol experiment with DMSO alone (b) was also performed. After cooling the samples, £uorescence polarization was measured at the
indicated temperature. The phospholipid concentration was 0.14 mM and the probe/phospholipid molar ratio was 1/500. The data are
representative of at least three independent experiments.
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peptide was unable to induce neither aggregation nor
fusion of egg PC liposomes. However, as depicted in
Fig. 4, the phase transition of liposomes composed of
DPH-labeled DMPC was also a¡ected by the addi-
tion of the N-terminal peptide. Interaction occurred
at the two pH values tested, with higher changes
observed at pH 5.0. As observed for both DMPS
and DMPG vesicles, the transition amplitude de-
creased while the Tm of the process remained con-
stant, indicative of the insertion of the peptide into
the core of the DMPC bilayer. A gradual decrease in
the transition enthalpy was attained as the peptide
concentration increased, although the complete can-
cellation of the phase transition was not observed in
the concentration range tested. At 28 WM peptide
concentration and pH 5.0 the transition amplitude
Fig. 3. Temperature dependence of the £uorescence polarization of DPH-labeled DMPG vesicles. The preparation of the vesicles and
the rest of the conditions are as in Fig. 2. 17.5 WM (F) and 28 WM (R) HBV peptide and control experiment with DMSO alone (b).
Fig. 4. Temperature dependence of the £uorescence polarization of DPH-labeled DMPC vesicles. The preparation of the vesicles and
the rest of the conditions are as in Fig. 2. 17.5 WM (F) and 28 WM (R) HBV peptide and control experiment with DMSO alone (b).
BBAMEM 77771 27-1-00
I. Rodr|¤guez-Crespo et al. / Biochimica et Biophysica Acta 1463 (2000) 419^428424
was reduced to 50%. Acidic pH values also aug-
mented somehow the degree of interaction of the
peptide with the liposomes, in accordance with the
likely protonation of the glutamic acid at position 2
above mentioned. The insertion of the peptide was
also assessed by di¡erential scanning calorimetry
(data not shown). The ¢ndings obtained are almost
identical using either approach: the interaction with
both acidic (DMPS) and zwitterionic (DMPC)
vesicles is accompanied by the concomitant decrease
in the enthalpy of the phase transition and with no
noticeable changes in the Tm of the process.
In order to compare the e¡ect of the peptide on
the thermotropic behavior of the various types of
phospholipids tested we have represented the changes
in the amplitude of the thermal transition (vP) at
increasing peptide/phospholipid molar ratios (Fig.
5). As de¢ned, the bigger the e¡ect on the phase
transition the higher the vP value. Also a vP value
close to 0.3 means an almost complete abolition of
the gel-to-liquid crystal transition. As it can be ob-
served in Fig. 5 at both pH values, there was a linear
correlation between the changes induced in the tran-
sition amplitude and the increase in the amount
of added peptide, with larger rates corresponding
to pH 5.0 and with the relative order
DMPGsDMPSsDMPC. In the case of DMPG
at pH 5.0, abrogation of the phase transition was
already achieved at a peptide/phospholipid ratio of
about 0.125. The fact that larger ratios induced no
additional changes in polarization would indicate
that every peptide molecule prevents an average of
8^10 phospholipid molecules from undergoing the
phase transition. Extrapolation of the linear increase
to a vP value of 0.3 allowed the calculation of the
number of phospholipid molecules a¡ected by an
individual peptide molecule in each case. Thus, de-
pending on the pH value of the interaction, 2^3
DMPC molecules, 3^5 DMPS molecules or 4^10
DMPG molecules were perturbed by every peptide
molecule.
The e¡ect of the N-terminal peptide was also eval-
uated by £uorescence depolarization of TMA-DPH
incorporated into DMPC and DMPS liposomes (Fig.
6). The addition of the peptide was re£ected in
changes in the thermotropic properties of surface re-
gions of the bilayer of DMPS vesicles. When the
fusion peptide was incubated with DMPC vesicles
at concentrations as high as 28 WM, the alterations
that were observed in the polarization of the TMA-
Fig. 5. Changes in the amplitude of the thermal transition of DPH-labeled vesicles with increasing peptide concentrations. At every
peptide/phospholipid molar ratio, the vP value was obtained by subtracting from the £uorescence polarization value measured at
maximal temperature the value of the control experiment performed in the presence of DMSO alone. Increasing amounts of the HBV
fusion peptide dissolved in DMSO were added to DMPC (b), DMPS (R) or DMPG (F) liposomes prepared at neutral (left) and acid
(right) pH values. The mixtures were allowed to stand for 1 h at 37‡C and the melting curve was recorded.
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DPH probe were almost negligible (Fig. 6, left). This
is clearly not the case for the DMPS vesicles (Fig. 6,
right) where the addition of the peptide clearly di-
minished the amplitude of the gel-to-£uid phase tran-
sition without promoting a modi¢cation in the Tm
value. At 28 WM peptide the reduction of the tran-
sition amplitude was 35%, decreasing the order of the
shallower region of the bilayer at temperatures below
the Tm and increasing the order at temperatures
above the Tm of the DMPS vesicles.
4. Discussion
Synthetic fusion peptides corresponding to the N-
terminus of viral envelope glycoproteins have been
widely used to determine the lipid destabilizing prop-
erties performed by these protein regions during the
initial infective steps [1,2]. Detailed structural studies
have been performed both in solution and in the
presence of lipids. Accordingly, the di¡erent second-
ary structures adopted by the peptides as well as the
di¡erent lipid compositions more suitable for aggre-
gation, lipid mixing and fusion have been deter-
mined. Thus, both K-helix and L-sheet structures
have been detected as the conformation of peptides
in their fusion-active form, in numerous cases de-
pending on the lipid composition and the lipid/pep-
tide ratio ([1,2] and references therein). On the other
hand, the conformational plasticity of the fusion
peptide together with its membrane-destabilizing
properties, rather than a certain structural conforma-
tion, appear to be the common determinants of these
N-terminal extensions [1,18].
Previous experiments performed in our laboratory
have shown that peptides derived from the N-termi-
nal region of three di¡erent members of the hepad-
navirus family destabilize model membranes e⁄-
ciently. They are £exible enough to adopt di¡erent
conformations when challenged in di¡erent environ-
ments and both extended and helical conformations
seem to be responsible for the destabilizing proper-
ties [9^11]. In the case of the HBV N-terminal pep-
tide stepwise sucrose gradient centrifugation allowed
to measure binding to soybean asolectin phospholip-
id vesicles. After incubation at pH 5.0 for 2 h at 37‡C
and a peptide/phospholipid molar ratio of 0.111 ap-
prox. 40% of the peptide was bound to the vesicles
[8]. Moreover, the peptide was able to induce aggre-
gation, lipid mixing as monitored by a £uorescent
probe dilution assay and release of aqueous contents
of bovine brain PS or soybean asolectin phospholipid
vesicles. However, these e¡ects could not be observed
when egg PC liposomes were used [9]. Although
these destabilizing properties are usually considered
the essential steps required for fusion [19], no direct
Fig. 6. Temperature dependence of the £uorescence polarization of TMA-DPH-labeled DMPC and DMPS vesicles. Liposomes were
prepared in medium bu¡er at pH 5.0. The rest of the conditions are as in Fig. 2, except that the probe/phospholipid molar ratio was
1/100. 17.5 WM (F) and 28 WM (R) HBV peptide and control experiment with DMSO alone (b).
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evidence for it had been reported. Electron micros-
copy studies performed under conditions in which
part of the peptide is bound to the vesicles show
that the N-terminal peptide is indeed fusogenic but
only towards negatively charged phospholipids. This
speci¢city points to the electrostatic interactions as a
key factor in eliciting the destabilization. Concerning
the preferences of fusion peptides towards the lipid
composition of the target membrane a great diversity
has been reported. Thus, an N-terminal fusion pep-
tide of in£uenza virus hemagglutinin was found to
preferentially interact with PC rather than PS vesicles
whereas the fusion peptide of vesicular stomatitis vi-
rus destabilized PS rather than PC liposomes [20].
More striking appeared to be the lipidic requirements
of the Ebola virus fusion peptide, where phosphati-
dylinositol rather than any other acidic phospholipid
was required in order to induce membrane fusion
[21]. A simple explanation to this behavior might
be found in the underlying tendency of the peptide
sequences to adopt a certain conformation in the
fusogenic state. Nevertheless, according to the CD
and Fourier transform infrared spectroscopy data,
the HBV fusion peptide adopted a L-sheet conforma-
tion in the presence of both neutral and acidic phos-
pholipids [11]. Hence, some other factor must ac-
count for the speci¢city towards negatively charged
vesicles.
The modi¢cation of the lipid-lipid interaction in-
duced by the HBV peptide under conditions that
induce aggregation and fusion was measured by
means of £uorescence depolarization. The data ob-
tained with the probe DPH showed that the HBV
fusion peptide inserted deeply within the DMPS
and DMPG bilayers, a¡ecting the gel-to-liquid crys-
tal transition by diminishing the amplitude value
without changing the Tm. These results point out
the relevance of the hydrophobic interaction in the
association of the peptide with the vesicles. On the
other hand, lowering the pH of the bu¡er resulted in
an increased interaction with liposomes, very likely
as a consequence of the partial protonation of gluta-
mic acid at position 2 in the sequence of the peptide.
Although the partial protonation of the carboxylate
of DMPS might be envisioned as the reason for this
improved interaction at acidic pH, the fact that at
pH 5.0 there is a very signi¢cant augmentation in the
interaction with DMPG vesicles suggests that a
change in the protonation state of the peptide, rather
than the lipid itself might be responsible for this
trend.
According to the DPH polarization experiments,
the fusion peptide was also able to insert within the
membrane interior of DMPC vesicles, decreasing the
enthalpy of the transition without inducing changes
in the value of the Tm. It must be remarked that
under the maximal concentration of peptide used in
the polarization studies (28 WM) neither vesicle ag-
gregation, lipid mixing nor leakage of egg PC lipo-
somes was observed, regardless of the pH of the
assay [9]. Moreover under the light of the electron
microscopy results, this insertion of the peptide with-
in the acyl moiety of the PC bilayer does not result in
vesicle fusion or aggregation, not even at concentra-
tions as high as 39 WM. On the other hand, when
DMPS vesicles were labeled with TMA-DPH,
changes in the £uidity of the membrane both below
and above the Tm of the transition were observed,
indicative that the peptide is disrupting a more super-
¢cial part of the bilayer. However, the peptide caused
an almost negligible disruption of that region of the
DMPC bilayers. Thus, fusion is only observed when
the peptide is able to interact with both the polar
head groups and the acyl chains, while alterations
of only the acyl chains do not result in membrane
fusion. This correlation between the fusion peptide
membrane penetration and its ability to promote ag-
gregation and fusion has also been reported for hu-
man immunode¢ciency virus (HIV) and Sendai virus
fusion peptides [22,23]. In these two cases, both wild-
type and mutant fusion peptides were labeled with
the £uorescent reagent NBD and their penetration
within the bilayer was monitored. Whereas the fu-
sion-defective V2E mutant of HIV was inserted deep-
er than the wild-type peptide inside the bilayer, the
more fusogenic G12A fusion peptide mutant of Sen-
dai virus was found to arrange closer to the surface
of the membrane than the wild-type [20,24]. There-
fore, there seems to be a general correlation and in
fact, it has been stated that a shallow penetration of
a fusion peptide is likely responsible for the destabi-
lization of the lipids required for coalescence of the
membranes and fusion [1].
The use of attenuated total re£ection Fourier-
transform infrared spectroscopy has allowed to de-
termine the orientation with respect to the bilayer
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plane of fusion peptides that insert in the bilayer in
an K-helical conformation. An oblique orientation
has been found to be a prerequisite for fusion of viral
peptides from simian immunode¢ciency virus [24,25],
HIV [26] and in£uenza virus [27,28] as well as a
peptide derived from fertilin, a protein active in
sperm-egg fusion [29]. However, when the peptide
display an extended L-structure, no orientation can
be experimentally determined [2]. Only indirect evi-
dence for an oblique orientation of HIV gp41-de-
rived peptides has been reported [23]. The fact that
HBV fusion peptide is able to disrupt both the polar
head group and the acyl chains of acidic phospho-
lipids would point to an oblique mode of insertion
while a perpendicular insertion in neutral phospho-
lipids would only a¡ect the hydrophobic core of the
bilayer. Also, the oblique insertion of HBV fusion
peptide in negatively charged phospholipids would
account for the higher number of phospholipid mol-
ecules that the peptide prevents from undergoing the
phase transition as compared with neutral phospho-
lipids. Accordingly, HBV and other L-sheet fusion
peptides may also induce the negative curvature
that favors the formation of inverted phases which
seem to be involved in fusion [25,29].
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